Management of locally advanced prostatic carcinoma by surgery: does screening for prostatic cancer make sense? David F. Paulson OriginalPaper Pages: 129 - 135
Stage A prostatic cancer: a comparative study in Japan and the Netherlands H. YamabeF. J. W. ten KateO. Yoshida OriginalPaper Pages: 136 - 140
Current problems in staging and grading prostatic carcinoma with special reference to T3 carcinoma of the prostate Ruud J. L. H. BoschFritz H. Schroeder OriginalPaper Pages: 141 - 146
Problems in grading of prostatic carcinoma: interobserver reproducibility of five different grading systems Fiebo J. W. ten KateMaarten P. W. GalleeJan H. M. Blom OriginalPaper Pages: 147 - 152
Evaluation of an enzyme-immunoassay for prostatic acid phosphatase utilizing monoclonal antibodies R. OosteromB. LeijnseF. H. Schroeder OriginalPaper Pages: 153 - 158
Transrectal ultrasonometry of the prostate: the prognostic relevance of volume changes under endocrine management P. J. CarpentierF. H. SchroederP. I. M. Schmitz OriginalPaper Pages: 159 - 162
Transrectal ultrasonography in diagnosis and staging of prostatic cancer G. EgenderA. FurtscheggerG. Bartsch OriginalPaper Pages: 163 - 170
The EORTC studies: is there an optimal endocrine management for M1 prostatic cancer? M. R. G. RobinsonJ. Hetherington OriginalPaper Pages: 171 - 175
Can the primary tumour be used as the sole parameter for response in phase II chemotherapy studies in metastatic prostate cancer? An EORTC Genito-Urinary Group Report W. G. JonesA. V. Bonomembers of the EORTC Genito-Urinary Tract Cancer Co-operative Group OriginalPaper Pages: 176 - 181
Mitomycin-C in the treatment of metastatic prostate cancer: report on an EORTC phase II study W. G. JonesS. D. Fossåmembers of the EORTC Genito-Urinary Tract Cancer Co-operative Group OriginalPaper Pages: 182 - 185
